"Williams backs Avacta, which is developing a 10-minute home saliva test for Covid-19. If approved by regulators, the test could be a “game-changer for social distancing and lockdown”, Williams says. “The share price has gone up significantly already,” he adds, “but this company could be a world leader if over 100 million of these tests are used each month.”